Dr. Bulumulle is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 Harris CT Bldg T Ste 201
Monterey, CA 93940Phone+1 831-375-4105
Education & Training
Vidant Medical Center/East Carolina UniversityFellowship, Hematology and Medical Oncology, 2020
Texas Tech University (Permian Basin)Residency, Internal Medicine, 2017
Kasturba Medical College ManipalClass of 2009
Certifications & Licensure
CA State Medical License 2024 - 2026
OR State Medical License 2020 - 2025
NC State Medical License 2016 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 10 citationsPatterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC.Rohini Sharma, Anjana Pillai, Thomas Urban Marron, Petros Fessas, Anwaar Saeed
Hepatology Communications. 2022-07-01 - 43 citationsTreatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with vali...David J. Pinato, Thomas U. Marron, Pallavi S. Mishra-Kalyani, Yutao Gong, Guo Wei
European Journal of Cancer. 2021-09-08 - 15 citationsAssociation of extended dosing intervals or delays in pembrolizumab-based regimens with survival outcomes in advanced non-small cell lung cancerKartik Sehgal, Anushi Bulumulle, Heather Brody, Ritu R. Gill, Shravanti Macherla
Clinical Lung Cancer. 2021-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
